Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Merck
Moodys
Boehringer Ingelheim
McKesson
Colorcon
Mallinckrodt

Last Updated: December 7, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Gasmotin

See Plans and Pricing

« Back to Dashboard

What is the drug development status for Gasmotin?

Gasmotin is an investigational drug.

There have been 10 clinical trials for Gasmotin. The most recent clinical trial was a Phase 3 trial, which was initiated on October 1st 2014.

The most common disease conditions in clinical trials are Gastritis, Dyspepsia, and Constipation. The leading clinical trial sponsors are Daewoong Pharmaceutical Co. LTD., Huazhong University of Science and Technology, and IlDong Pharmaceutical Co Ltd.

There are forty-one US patents protecting this investigational drug and four hundred and thirty-two international patents.

Recent Clinical Trials for Gasmotin
TitleSponsorPhase
Efficacy and Safety of DWJ1252 in the Treatment of Functional Dyspepsia (PART 2)Daewoong Pharmaceutical Co. LTD.Phase 3
Efficacy and Safety of DWJ1252 in the Treatment of Functional DyspepsiaDaewoong Pharmaceutical Co. LTD.Phase 3
Efficacy and Safety of UI05MSP015CT in Functional DyspepsiaKorea United Pharm. Inc.Phase 3

See all Gasmotin clinical trials

Clinical Trial Summary for Gasmotin

Top disease conditions for Gasmotin
Top clinical trial sponsors for Gasmotin

See all Gasmotin clinical trials

US Patents for Gasmotin

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Gasmotin   Start Trial Cellulose micropowder ASAHI KASEI KABUSHIKI KAISHA (Tokyo, JP)   Start Trial
Gasmotin   Start Trial Food, beverage or pharmaceutical composition containing fermented eastern prickly pear and a preparation method therefor   Start Trial
Gasmotin   Start Trial Method for rapid testing allergy Shibaguchi; Hirotomo (Fukuoka-Shi, Fukuoka, JP)   Start Trial
Gasmotin   Start Trial Disintegrating tablet in oral cavity and production thereof Dainippon Pharmaceutical Co., Ltd. (Osaka-fu, JP)   Start Trial
Gasmotin   Start Trial Colonic motor dysfunction remedies comprising aminothiazole derivatives as active ingredients Zeria Phamaceutical Co., Ltd. (Tokyo, JP)   Start Trial
Gasmotin   Start Trial Pharmaceutical composition containing mosapride and pancreatin Osmotica Corp. (Tortola, VG)   Start Trial
Gasmotin   Start Trial Crude drug composition for preventing and treating gastrointestinal dyskinetic diseases Helixir Co., Ltd. (KR)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Gasmotin

Drugname Country Document Number Estimated Expiration Related US Patent
Gasmotin European Patent Office 3181616 2034-08-12   Start Trial
Gasmotin Japan 6216074 2034-08-12   Start Trial
Gasmotin Japan WO2016024493 2034-08-12   Start Trial
Gasmotin Taiwan 201613646 2034-08-12   Start Trial
Gasmotin Taiwan I572360 2034-08-12   Start Trial
Gasmotin World Intellectual Property Organization (WIPO) 2016024493 2034-08-12   Start Trial
Gasmotin China 105451577 2033-08-09   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
McKesson
McKinsey
AstraZeneca
Colorcon
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.